These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16629938)

  • 1. Survival of patients with early hepatocellular carcinoma treated by percutaneous alcohol injection.
    Andriulli A; De Sio I; Brunello F; Salmi A; Solmi L; Facciorusso D; Caturelli E; Perri F
    Aliment Pharmacol Ther; 2006 May; 23(9):1329-35. PubMed ID: 16629938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival of cirrhotic patients with early hepatocellular carcinoma treated by percutaneous ethanol injection or liver transplantation.
    Andriulli A; de Sio I; Solmi L; De Carlis L; Troisi R; Grasso A; Festa V; Caturelli E; Giacomoni A; Del Vecchio Blanco C; De Hemptinne B; Burroughs A; Perri F
    Liver Transpl; 2004 Nov; 10(11):1355-63. PubMed ID: 15497162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection.
    Castells A; Bruix J; Bru C; Fuster J; Vilana R; Navasa M; Ayuso C; Boix L; Visa J; Rodés J
    Hepatology; 1993 Nov; 18(5):1121-6. PubMed ID: 8225217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma: comparison with percutaneous ethanol injection therapy.
    Seki T; Wakabayashi M; Nakagawa T; Imamura M; Tamai T; Nishimura A; Yamashiki N; Okamura A; Inoue K
    Cancer; 1999 Apr; 85(8):1694-702. PubMed ID: 10223562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence.
    Pompili M; Mirante VG; Rondinara G; Fassati LR; Piscaglia F; Agnes S; Covino M; Ravaioli M; Fagiuoli S; Gasbarrini G; Rapaccini GL
    Liver Transpl; 2005 Sep; 11(9):1117-26. PubMed ID: 16123960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis of hepatocellular carcinoma with no tumor stain treated by percutaneous ethanol injection.
    Ueno H; Okada S; Okusaka T; Ikeda M; Tanaka N; Sakamoto M; Yoshimori M
    Hepatogastroenterology; 2001; 48(41):1430-4. PubMed ID: 11677980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis.
    Livraghi T
    Hepatogastroenterology; 2001; 48(37):20-4. PubMed ID: 11268965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of small hepatocellular carcinoma with percutaneous ethanol injection: a validated prognostic model.
    Orlando A; D'Antoni A; Cammà C; Albanese M; Livraghi T; Torzilli G; Virdone R; Sciarrino E; Simonetti RG; Maringhini A; Pagliaro L; Cottone M
    Am J Gastroenterol; 2000 Oct; 95(10):2921-7. PubMed ID: 11051369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous Ethanol Injection in the treatment of hepatocellular carcinoma in cirrhosis.
    Livraghi T
    Hepatogastroenterology; 1998 Aug; 45 Suppl 3():1248-53. PubMed ID: 9730383
    [No Abstract]   [Full Text] [Related]  

  • 10. [Locoregional treatment of hepatocellular carcinoma: comparison between percutaneous alcohol administration and intraarterial chemoembolization].
    Cioni G; Turrini F; Pedrazzini PG; Cristani A; Ventura E; Ferrari A; D'Alimonte P; Ariosi P; De Santis M
    Recenti Prog Med; 2002 Jun; 93(6):361-6. PubMed ID: 12085715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Percutaneous alcohol administration for hepatocarcinoma: long-term results].
    Lencioni R; Paolicchi A; Bartolozzi C
    Radiol Med; 1997; 94(1-2):8-13. PubMed ID: 9424657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factors for recurrence after percutaneous ethanol injection for solitary hepatocellular carcinoma.
    Ishii H; Okada S; Nose H; Okusaka T; Nagahama H; Nakayama H; Nakasuka H; Yoshimori M
    Hepatogastroenterology; 1996; 43(10):938-43. PubMed ID: 8884317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous treatment of hepatocellular carcinoma in patients with transjugular intrahepatic portosystemic shunts.
    Tesdal IK; Wikström M; Flechtenmacher C; Filser T; Dueber C
    Cardiovasc Intervent Radiol; 2006; 29(5):778-84. PubMed ID: 16779690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of intrahepatic recurrence by adjuvant (131)iodine-labeled lipiodol after resection for hepatocellular carcinoma in HCV-related cirrhosis.
    Tabone M; Vigano' L; Ferrero A; Pellerito R; Carbonatto P; Capussotti L
    Eur J Surg Oncol; 2007 Feb; 33(1):61-6. PubMed ID: 17175128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radio-frequency thermal ablation (RFTA) of small hepatocellular carcinoma in patients with cirrhosis. Experience at a single tertiary referral center.
    Licata A; Di Marco V; Parisi P; Latteri F; Nebbia ME; Cabibbo G; Di Bona D; Prinzi G; Li Petri S; Sandonato L; Latteri MA; Craxì A; Cammà C
    Minerva Gastroenterol Dietol; 2005 Jun; 51(2):171-8. PubMed ID: 15990706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous ethanol injection of hepatocellular carcinoma: survival after 3 years in 70 patients.
    Livraghi T
    Ital J Gastroenterol; 1992 Feb; 24(2):72-4. PubMed ID: 1315592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors of survival after percutaneous radiofrequency ablation of hepatocellular carcinoma.
    Peng ZW; Zhang YJ; Chen MS; Liang HH; Li JQ; Zhang YQ; Lau WY
    Surg Oncol; 2008 Jul; 17(1):23-31. PubMed ID: 17869095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous ethanol injection therapy in 47 cirrhotic patients with hepatocellular carcinoma 5 cm or less: a long-term result.
    Lin SM; Lin DY; Lin CJ
    Int J Clin Pract; 1999 Jun; 53(4):257-62. PubMed ID: 10563068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival impact of delayed treatment in patients with hepatocellular carcinoma undergoing locoregional therapy: is there a lead-time bias?
    Huo TI; Huang YH; Chiang JH; Wu JC; Lee PC; Chi CW; Lee SD
    Scand J Gastroenterol; 2007 Apr; 42(4):485-92. PubMed ID: 17454859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma.
    Ohnishi K
    Hepatogastroenterology; 1998 Aug; 45 Suppl 3():1254-8. PubMed ID: 9730384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.